The Microbiology Society is pleased to present Anaerobe 2021 in association with the Society for Anaerobic Microbiology. Anaerobic bacteria are predominant members of the normal human microbiota and well recognised as lethal pathogens. Aspects of their virulence, antimicrobial resistance and interactions with the human host will be highlighted during the Anaerobe 2021 Focused Meeting. Infectious diseases relating to Gram negative anaerobes including the Bacteroidetes, such as Bacteroides, Prevotella and Porphyromonas, will be discussed, as well as their role as drivers of diseases such as cancer and Alzheimer’s. The meeting will also include important clostridial infection and treatment updates.
Anaerobe 2021 will provide clinical microbiologists, infectious disease researchers and specialists with insights into the current and future impact of anaerobic bacteria in human health and disease. Researchers studying oral, gastrointestinal tract and female genital system microbiomes will gain key scientific insights into these important members of the microbiota and colonisers of humans.
Offered papers relating to aspects of anaerobic bacteria in human health and disease will be considered for presentation within the symposium.
Please find below more information about our invited speakers, who will present their work and research at Anaerobe 2021: the microbiota and beyond.
Joanne M. Santini is a Professor of Microbiology at UCL and Chair of the UCL Microbiology Domain. JMS obtained her PhD in Microbiology at La Trobe University, Melbourne, Australia in 1999. In 2000 she became an independent group leader and was awarded an Australian Research Council Australian Postdoctoral fellowship. She moved to London in 2006 as a lecturer in Environmental Biology at UCL. She is interested in all microbial life having worked on bacterial plasmids and bacterial conjugation, microbial metabolism of arsenic and more recently viruses, including host-range of SARS-CoV-2, and the gut microbiome of humans and animals with a particular focus on bacteriophages. Her collaboration with Jill Banfield (UC Berkeley) led to the recent discovery of the largest phage ever identified in the gut, designated Lak, which preys on Prevotella species. Twitter: @microbiologyucl
Dr. Boleij obtained her PhD on the association between infections with the opportunistic gut pathogen Streptococcus gallolyticus and gastrointestinal tumors. In 2012 she was awarded a Rubicon grant of NWO to conduct research on oncotoxin producing Bacteroides fragilis at Johns Hopkins Medical Institutions. Her research revealed the frequent detection of the oncotoxin in the gut mucosa of CRC patients and elucidated part of the epithelial signaling mechanism of this bacterial oncotoxin. In 2014 she started her research group at the Department of Pathology of the Radboudmc and was awarded a prestigious Veni-grant from NWO. With her research group Dr. Boleij focuses on members of the microbiome with potential cancer promoting or inhibiting effects especially in patients with a high risk for CRC. The ultimate goal is to understand whether microbes play a role in the pathogenesis of CRC and whether microbes can predict if patients are at increased risk. LinkedIn: Annemarie Boleij
Robert Fagan is a molecular microbiologist whose work for the past 16 years has focused on the anaerobic human pathogen Clostridioides difficile and related species. His lab at the University of Sheffield combines classical bacterial genetics, with protein biochemistry and structural biology by X-ray crystallography and cryo-EM. In addition to projects on the biogenesis and function of cell surface structures, sporulation and germination, the Fagan lab specialise in the development of new genetic tools and high-throughput methods for analysis of gene function.
The foundation of Hilary’s work is based upon culturing of the strict anaerobic bacteria that comprise the majority of the human intestinal microbiota. Whole genome sequencing of the isolated bacteria facilitates genomic and metagenomic analyses, this combined with in vitro phenotypic studies leads to functional insights and a move towards establishing causation in different disease states. Hilary is particularly interested in the role of spore-forming bacteria in the human intestinal microbiota. Spores are dormant resilient structures that promote transmission of anaerobic bacteria (both harmful and beneficial) between hosts. Hilary seeks to understand the ecology and evolution of bacterial spore-formers and their functions in the human intestinal microbiota. Twitter: @hilary_browne
Lindsay has recently been appointed as the Chair of Intestinal Microbiome at the Technical University of Munich (Germany) and is a Wellcome Investigator. She also holds a group leader position at the Quadram Institute (UK). The lab’s research focus involves defining microbe/microbiota interactions during the early life developmental window. She obtained a BSc in Microbiology from the University of Glasgow, a PhD in Microbiology and Immunology from the University of Cambridge (Wellcome Trust Sanger Institute), and was a postdoctoral fellow at University College Cork, Ireland (APC Microbiome Institute). She returned to the UK to take up a Senior Lectureship at the University of East Anglia before moving to Quadram end of 2015. Twitter: @hall_lab; Linkedin: Lindsay Hall
Dr Jane Freeman is a Clinical Scientist in microbiology at Leeds Teaching Hospitals Trust and an HEE/NIHR ICA Clinical Lecturer. She holds a visiting researcher position at the University of Leeds. She completed her PhD on Antibiotics and C. difficile with Prof Mark Wilcox in 2001, which was the start of a career-long interest in this organism. After a post-doctoral position in Prof. Wilcox' lab, Jane moved to the NHS to train as a clinical scientist, specialising in healthcare associated infections, and helping to establish the highly successful Healthcare Associated Infections Research group at Leeds - a multi-organisation research group bringing together academics and scientists from UoL, LTHT and PHE. Jane's particular research interests are antimicrobial resistance in C. difficile, gut dysbiosis and paediatric CDI; she is also a strong advocate of research careers and opportunities for healthcare scientists within the NHS. Twitter: @HCAILeeds
Abstract submission for the Anaerobe 2021 meeting is now closed.
Notifications of acceptance will be sent w/c 3 May 2021.
Anaerobe 2021 will be accessible remotely and will use virtual event technology to provide a comprehensively curated scientific programme for the conference.
A link will be updated on this page closer to the event to allow you to access the virtual platform via your web browser. We advise that you use the Google Chrome browser to ensure best optimisation.
When prompted, please enter your email address and set-up a password to access the event platform. Please note, the email address you use here should be the same email address that you used to register your place. Once you have signed in, you will be asked to set up a short profile, allowing other attendees to see some basic details about you.
If you have any issues signing into the platform, please email [email protected].
Society Conference Grants of up to £10 are available to support eligible members wishing to present at the Annual Conference. Support is also available for members requiring support for caring costs associated with conference attendance. Full information is available on the Society Conference Grant page.
Applications will open for a two-week period from 6–20 May 2021 for support towards conference registration.
If you are a member who is not eligible for a Society Conference Grant, please apply via the Travel Grant scheme (deadline: 1 June 2021).
Please contact [email protected] for further queries.
Registration is now open.
Members get heavily subsidised registration fees for Annual Conference, Focused Meetings and other Society events – both online and in-person. Join now to enjoy these discounts and many other opportunities that are designed for microbiologists at all stages of their career.
|
Non-member |
£60 |
|
Full member |
£20 |
|
Concessionary member |
£10 |
|
Student member |
£10 |
|
Affiliate Member |
£30 |
To ensure the meeting remains of value for the scientific community, small charges apply to reflect some of the incurred costs associated to delivering the online meeting.
Upon registration, you should receive an automated confirmation email. Please contact [email protected] if after 24 hours this has not been received.
All registration fees must be paid in full before the start of the event. Any outstanding registration fees must be paid before any joining instructions containing information on how to access the event are sent out.
Please inform the conferences team if you can no longer attend the event after registering by contacting [email protected]. Refunds are not provided; however, substitutions of attendees can be made at any time.
Exhibition and sponsorship opportunities are available for this meeting.
Please download our exhibition pack to view our exciting new digital exhibition and sponsorship options, suiting varying budgets and help create the opportunities you need to connect with new and existing customers. If you have any questions about the packages or the digital options available please email [email protected]
Anaerobe 2021 Sponsorship Pack
Anaerobe 2021 Technical Specifications and Guidelines
